PTK2 and breast carcinoma: Though it has been shown previously that 14,15-EET induced breast cancer cell EMT and drug resistance via activation of the integrin/FAK signaling axes [26], our findings pinpoint that CYP epoxygenase expression and all the 4 EET isomers are more relevant to the mesenchymal-like TNBC subtype.